Monopar Therapeutics
BioTech/Drugs - Wilmette, IL, US
Monopar Therapeutics Employees
Monopar Therapeutics Senior Management
Monopar Therapeutics Details
Monopar Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Monopar's pipeline consists of Validive® for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin for the treatment of advanced soft tissue sarcoma; and a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19.
Website:
monopartx.com
Employees:
20 - 49
HQ:
847-388-0349
Location:
Wilmette, IL, US
Revenue:
2.5 - 5 Million
Monopar Therapeutics Technologies
Captcha
reCAPTCHA
Email Providers
Outlook
Load Balancers
Apache
Other
Microsoft Office 365
Hosting
Amazon AWS
Analytics and Tracking
Google Analytics